| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue |
| 02/28/2013 | CA2848896A1 Dyrk1 inhibitors and uses thereof |
| 02/28/2013 | CA2846611A1 Compositions and methods for treating neurodegenerative disease |
| 02/28/2013 | CA2846604A1 Compositions and methods for treating neurodegenerative disease |
| 02/28/2013 | CA2846204A1 Pyridazinone compounds and their use as daao inhibitors |
| 02/28/2013 | CA2845578A1 Pyrimidine pde10 inhibitors |
| 02/28/2013 | CA2845093A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 02/28/2013 | CA2844988A1 2-spiro-substituted iminothiazines and their mono- and dioxides as bace inhibitors, compositions, and their use |
| 02/28/2013 | CA2844764A1 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands |
| 02/27/2013 | EP2562545A1 Methods and compositions relating to Alzheimer's disease |
| 02/27/2013 | EP2562176A1 Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same |
| 02/27/2013 | EP2562168A1 Therapeutic piperazines as PDE4 inhibitors |
| 02/27/2013 | EP2561886A1 Peptide adjuvant for improved peripheral analgesia |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2561865A2 Transdermal absorption preparation |
| 02/27/2013 | EP2561860A1 Implantable polymeric device for sustained release of buprenorphine |
| 02/27/2013 | EP2560974A1 Pyrrazolopyridine derivatives |
| 02/27/2013 | EP2560973A1 Modulators of 5-ht receptors and methods of use thereof |
| 02/27/2013 | EP2560972A2 Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | EP2560966A2 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/27/2013 | EP2560953A2 Novel inhibitors |
| 02/27/2013 | EP2560942A1 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis |
| 02/27/2013 | EP2560687A2 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| 02/27/2013 | EP2560676A1 Organic compounds |
| 02/27/2013 | EP2560671A2 High affinity leptins and leptin antagonists |
| 02/27/2013 | EP2560646A2 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain |
| 02/27/2013 | EP2560631A2 Baclofen and acamprosate based therapy of neurogical disorders |
| 02/27/2013 | CN102947310A Anellated pyridine compounds as dual modulators of the 5-HT2A and D3 receptors |
| 02/27/2013 | CN102947305A Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | CN102947302A Triazolo [4, 5 - b] pyridin derivatives |
| 02/27/2013 | CN102947301A Quinolizidine and indolizidine derivatives |
| 02/27/2013 | CN102947297A Amido-tropane derivatives |
| 02/27/2013 | CN102947295A 3,3-disubstituted-(8-aza-bicyclo [3.2.1]oct-8-y)-[5-(1 -pyrazol-4-yl)-thiophe-3-yl] methanones as inhibitors of 11[beta]-HSD1 |
| 02/27/2013 | CN102947292A Nitrogen containing heteroaryl compounds |
| 02/27/2013 | CN102947289A Arylethynyl derivatives |
| 02/27/2013 | CN102946908A Inhibitor of expression of dominant allele |
| 02/27/2013 | CN102946896A Sox9 inhibitors |
| 02/27/2013 | CN102946877A Neuro-protective effects of adelostemma gracillimum and its isolated compounds |
| 02/27/2013 | CN102946873A Transdermal absorption preparation |
| 02/27/2013 | CN102946859A Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102942569A Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 02/27/2013 | CN102942567A Disodium salt crystal of pyrroloquinoline quinone |
| 02/27/2013 | CN102942538A Substituted benzhydryl piperazine derivative and preparation method and application thereof |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940878A Spinal nucleus pulposus implant |
| 02/27/2013 | CN102940857A Medicine composition for treating depression and preparation method thereof |
| 02/27/2013 | CN102940852A Traditional Chinese machine preparation for treating pseudobulbar paralysis |
| 02/27/2013 | CN102940849A Chinese medicine fumigation composition for adjunctive therapy of spastic cerebral palsy |
| 02/27/2013 | CN102940837A Chinese medicinal composition for treating migraine |
| 02/27/2013 | CN102940834A Traditional Chinese medicine for treating senile dementia |
| 02/27/2013 | CN102940796A Traditional Chinese medicine composition for treating migraine and preparation method thereof |
| 02/27/2013 | CN102940790A Chinese medicament for treating migraine |
| 02/27/2013 | CN102940789A Chinese medicament for treating liver-yang headache |
| 02/27/2013 | CN102940788A Traditional Chinese medicine composition for treating mental disease and preparation method thereof |
| 02/27/2013 | CN102940784A Active fresh Gastrodia elata full pulp soft capsule |
| 02/27/2013 | CN102940783A Active fresh Gastrodia elata superfine powder and preparation method thereof |
| 02/27/2013 | CN102940781A Anti-aging and dredging Chinese medicinal composition |
| 02/27/2013 | CN102940770A Traditional Chinese medicine for treating acute inflammatory demyelinating polyneuropathy |
| 02/27/2013 | CN102940768A Composition for improving sleep and preparation method and application thereof |
| 02/27/2013 | CN102940761A Traditional Chinese medicine for treating graphospasm |
| 02/27/2013 | CN102940749A Traditional Chinese medicine paste for treatment of diabetic foot |
| 02/27/2013 | CN102940731A Preparation technology of Anshenbao particle extractive |
| 02/27/2013 | CN102940705A Chinese medicament capable of giving up drug addiction |
| 02/27/2013 | CN102940629A New use of Tubacin |
| 02/27/2013 | CN102940620A Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivates and their uses |
| 02/27/2013 | CN102940614A Method for preparing bulleyaconitine-containing tablets |
| 02/27/2013 | CN102940605A Piribedil sustained release preparation and preparation method thereof |
| 02/27/2013 | CN102634431B Method for brewing dendrobium nobile wine |
| 02/27/2013 | CN102552591B Application of pain-relief anti-inflammation ointment to curing cerebral edema of contusion and laceration of brain |
| 02/27/2013 | CN102284052B Lavipeditum traditional Chinese medicine composition for treating insomnia |
| 02/27/2013 | CN102267966B Substituted benzopyrone derivatives and application thereof |
| 02/27/2013 | CN102204967B Preparation method for safflower care-free tablet |
| 02/27/2013 | CN102188363B Transdermal medicament delivery system containing donepezil compound, preparation and preparation method |
| 02/27/2013 | CN102160894B Benzamide analog mediated brain-targeting delivery system |
| 02/27/2013 | CN102115429B (E)-1-(3,5-dimethoxyphenyl)-2-(3,5-dihydroxy-4-methoxyphenyl)ethylene, and preparation method and application thereof |
| 02/27/2013 | CN102080083B Human miR-149 antisense nucleotide and application thereof |
| 02/27/2013 | CN101918359B Sulfonamides as orexin antagonists |
| 02/27/2013 | CN101863962B Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof |
| 02/27/2013 | CN101827828B 1, 2, 4 -triazole derivatives as serotonergic modulators |
| 02/27/2013 | CN101798317B N-substituted aminothiazole morphinan compound and preparation method and applications thereof |
| 02/27/2013 | CN101798297B Chemical synthesis method of laetispicine |
| 02/27/2013 | CN101683459B Application of a traditional Chinese medicine composition in preparation of medicament for treating sleep disorder |
| 02/27/2013 | CN101632740B Chinese medicinal composition for regulating blood fat and improving sleeping and preparation method thereof |
| 02/27/2013 | CN101623278B Medicinal composition containing levodopa and benserazide hydrochloride |
| 02/27/2013 | CN101623250B Levetiracetam medicinal composition and preparation method thereof |
| 02/27/2013 | CN101463084B Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 02/26/2013 | US8383675 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| 02/26/2013 | US8383667 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium |
| 02/26/2013 | US8383650 Organic compounds |
| 02/26/2013 | US8383626 Nitric oxide donors for inducing neurogenesis |
| 02/26/2013 | US8383162 PHα1B toxin, CDNA of PHα1B toxin gene, pharmaceutical composition containing PHα1B toxin, process for their production and product |
| 02/26/2013 | CA2727899C Delayed release rasagiline formulation |
| 02/26/2013 | CA2572544C Modified pyrimidine glucocorticoid receptor modulators |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/21/2013 | WO2013026064A1 Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
| 02/21/2013 | WO2013026060A1 The islet amyloid polypeptide toxic oligomer is a biomarker of brain alteration in type-2 diabetes mellitus |
| 02/21/2013 | WO2013025607A1 Methods of treating amyloidoses with vitamin b12 and test for detecting amyloid-beta peptides |
| 02/21/2013 | WO2013025474A2 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |